Direct-To-Consumer Healthcare And Its Expanding Role In The Australian Healthcare System

January 2026 in “ Internal Medicine Journal ”

Jingwen Lu, Deshan F. Sebaratnam

TLDR Direct-to-consumer telemedicine in Australia needs formal evaluation for safety and quality.

Direct-to-consumer telemedicine services are gaining popularity in Australia, offering virtual consultations and electronic prescriptions. Despite their benefits, there are concerns about safety, privacy, and ethics. To ensure these platforms provide high-value and high-quality care, a formal evaluation within the Australian healthcare system is necessary.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Direct-To-Consumer Androgenetic Alopecia Treatments: A Cost Comparison With Traditional Pharmacies

September 2024 in “Journal of the American Academy of Dermatology”

research Patient-Reported Outcomes and Safety of Direct-to-Consumer Teledermatology for Finasteride in Male Androgenetic Alopecia

January 2023 in “DIGITAL HEALTH”

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment

research Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment

24 citations , September 2020 in “Dermatology and therapy”

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.